Exact Mass: 367.1856

Exact Mass Matches: 367.1856

Found 76 metabolites which its exact mass value is equals to given mass value 367.1856, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

6-hydroxytryprostatin B

6-Hydroxytryprostatin B; Desmethyltryprostatin A

C21H25N3O3 (367.1896)


A cyclic dipeptide that is brevianamide F (cyclo-L-Trp-L-Pro) substituted at positions 2 and 6 on the indole ring by prenyl and hydroxy groups respectively.

   

{4-[4-(6-Carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid

2-{4-[4-(6-carbamoyl-3,5-dimethylpyrazin-2-yl)phenyl]cyclohexyl}acetic acid

C21H25N3O3 (367.1896)


AZD7687 is a potent, selective, reversible and orally active diacylglycerol acyltransferase 1 (DGAT1) inhibitor with an IC50 of 80 nM for human DGAT1. AZD7687 can be used for type 2 diabetes mellitus and obesity research[1][2].

   

N-Allylsecoboldine

3,5-dimethoxy-8-{2-[methyl(prop-2-en-1-yl)amino]ethyl}phenanthrene-2,6-diol

C22H25NO4 (367.1783)


   

4-[[1-(4-Tert-Butylphenyl)-5-oxo-3-pyrrolidinyl]methoxy]benzoic acid

4-{[1-(4-tert-butylphenyl)-5-oxopyrrolidin-3-yl]methoxy}benzoic acid

C22H25NO4 (367.1783)


   
   
   

Knightolamine

Knightolamine

C22H25NO4 (367.1783)


   

Desmethyltryprostatin A

Desmethyltryprostatin A

C21H25N3O3 (367.1896)


   

6-Hydroxydeoxybrevianamide E

6-Hydroxydeoxybrevianamide E

C21H25N3O3 (367.1896)


   
   

6-benzoyloxy-2-(hydroxy-phenyl-methyl)-8-methyl-nortropan-3-ol

6-benzoyloxy-2-(hydroxy-phenyl-methyl)-8-methyl-nortropan-3-ol

C22H25NO4 (367.1783)


   
   
   

marmesiline|N-[2-hydroxy-2-[4-[(2-hydroxy-3-methyl-3-butenyl)oxy]phenyl]ethyl]-3-phenyl-(2E)-2-propenamide

marmesiline|N-[2-hydroxy-2-[4-[(2-hydroxy-3-methyl-3-butenyl)oxy]phenyl]ethyl]-3-phenyl-(2E)-2-propenamide

C22H25NO4 (367.1783)


   

4-[3-[N-[[(2S,3S)-3-trans-carboxyoxiran-2-yl]carbonyl]-L-leucyl]aminopropanyl]-1H-imidazol-2-ylamine|WF14865B

4-[3-[N-[[(2S,3S)-3-trans-carboxyoxiran-2-yl]carbonyl]-L-leucyl]aminopropanyl]-1H-imidazol-2-ylamine|WF14865B

C16H25N5O5 (367.1856)


   

daphnicyclidin A

daphnicyclidin A

C22H25NO4 (367.1783)


   

1,2,9,10-tetramethoxy-6,7-dimethyl-5,6-dihydro-4H-dibenzo[de,g]quinoline

1,2,9,10-tetramethoxy-6,7-dimethyl-5,6-dihydro-4H-dibenzo[de,g]quinoline

C22H25NO4 (367.1783)


relative retention time with respect to 9-anthracene Carboxylic Acid is 1.137 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.143

   

N-Desethylquinagolide

N-Desethylquinagolide

C18H29N3O3S (367.193)


   
   

Fmoc-7-Ahp-OH

Fmoc-7-Ahp-OH

C22H25NO4 (367.1783)


   

Dimoxyline

1-[(4-ethoxy-3-methoxyphenyl)methyl]-6,7-dimethoxy-3-methylisoquinoline

C22H25NO4 (367.1783)


C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

Fmoc-N-Me-Leu-OH

Fmoc-N-Me-Leu-OH

C22H25NO4 (367.1783)


   

3-METHYL-4-(4-(PYRIDIN-2-YLMETHOXY)CYCLOHEXANECARBOXAMIDO)BENZAMIDE

3-METHYL-4-(4-(PYRIDIN-2-YLMETHOXY)CYCLOHEXANECARBOXAMIDO)BENZAMIDE

C21H25N3O3 (367.1896)


   

benzyl(triphenyl)phosphanium,boranuide

benzyl(triphenyl)phosphanium,boranuide

C25H25BP (367.1787)


   

Fmoc-β-Homo-Leu-OH

Fmoc-β-Homo-Leu-OH

C22H25NO4 (367.1783)


   

Fmoc-Neopentylglycine

Fmoc-Neopentylglycine

C22H25NO4 (367.1783)


   

Fmoc-N-Me-Ile-OH

Fmoc-N-Me-Ile-OH

C22H25NO4 (367.1783)


   

Fmoc-N-Methyl-D-leucine

Fmoc-N-Methyl-D-leucine

C22H25NO4 (367.1783)


   

4-METHYL-3-(4-(PYRIDIN-2-YLMETHOXY)CYCLOHEXANECARBOXAMIDO)BENZAMIDE

4-METHYL-3-(4-(PYRIDIN-2-YLMETHOXY)CYCLOHEXANECARBOXAMIDO)BENZAMIDE

C21H25N3O3 (367.1896)


   

Pramiracetam sulfate

Pramiracetam sulfate

C14H29N3O6S (367.1777)


C26170 - Protective Agent > C1509 - Neuroprotective Agent

   

(R)-N-FMoc-α-Methylleucine

(R)-N-FMoc-α-Methylleucine

C22H25NO4 (367.1783)


   

Fmoc-HomoLeu-OH

Fmoc-HomoLeu-OH

C22H25NO4 (367.1783)


   

Fmoc-β-homoisoleucine

Fmoc-β-homoisoleucine

C22H25NO4 (367.1783)


   

1,4-divinylbenzene,isocyanatomethylbenzene,styrene

1,4-divinylbenzene,isocyanatomethylbenzene,styrene

C26H25NO (367.1936)


   

Pitofenone

pitofenone hcl

C22H25NO4 (367.1783)


C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent

   

3-(9H-fluoren-9-ylmethoxycarbonylamino)heptanoic acid

3-(9H-fluoren-9-ylmethoxycarbonylamino)heptanoic acid

C22H25NO4 (367.1783)


   

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-leucine

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-2-methyl-L-leucine

C22H25NO4 (367.1783)


   

Tiracizine

CARBAMIC ACID

C21H25N3O3 (367.1896)


C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C - Cardiovascular system > C01 - Cardiac therapy

   

2,6-Difluoro-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

2,6-Difluoro-3,5-bis(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

C17H25B2F2NO4 (367.1938)


   

Benzoicacid, 2-[4-(cyclohexylethylamino)-2-hydroxybenzoyl]-

Benzoicacid, 2-[4-(cyclohexylethylamino)-2-hydroxybenzoyl]-

C22H25NO4 (367.1783)


   

Fmoc-D-Homoleucine

Fmoc-D-Homoleucine

C22H25NO4 (367.1783)


   

1-[4-(Aminomethyl)benzoyl]-5-fluoro-1H-spiro[piperidine-4,2-quinazolin]-4-amine

1-[4-(Aminomethyl)benzoyl]-5-fluoro-1H-spiro[piperidine-4,2-quinazolin]-4-amine

C20H22FN5O (367.1808)


   

2-N-acetylparomamine(2+)

2-N-acetylparomamine(2+)

C14H29N3O8+2 (367.1955)


   

(3E)-3-[(2E,4E,6E)-1-hydroxy-8-methyldeca-2,4,6-trienylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione

(3E)-3-[(2E,4E,6E)-1-hydroxy-8-methyldeca-2,4,6-trienylidene]-5-[(4-hydroxyphenyl)methyl]pyrrolidine-2,4-dione

C22H25NO4 (367.1783)


   

Ipratropium chloride

Ipratropium chloride

C20H30ClNO3 (367.1914)


   

N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(2-methylphenoxy)acetamide

N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(2-methylphenoxy)acetamide

C21H25N3O3 (367.1896)


   

(2S,3S)-3-{[(2S)-1-{[3-(2-amino-1H-imidazol-4-yl)propyl]amino}-4-methyl-1-oxopentan-2-yl]carbamoyl}oxirane-2-carboxylic acid

(2S,3S)-3-{[(2S)-1-{[3-(2-amino-1H-imidazol-4-yl)propyl]amino}-4-methyl-1-oxopentan-2-yl]carbamoyl}oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

(3R,3aS,7R,7aS)-7-methyl-3-(2-naphthalenyl)-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

(3R,3aS,7R,7aS)-7-methyl-3-(2-naphthalenyl)-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

C26H25NO (367.1936)


   

N-hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]octanediamide

N-hydroxy-N-[(E)-(4-phenylphenyl)methylideneamino]octanediamide

C21H25N3O3 (367.1896)


   

N-hydroxy-N-[(E)-[4-(2-methylphenyl)phenyl]methylideneamino]heptanediamide

N-hydroxy-N-[(E)-[4-(2-methylphenyl)phenyl]methylideneamino]heptanediamide

C21H25N3O3 (367.1896)


   

(2S,3S)-3-{[(2R)-1-{[3-(2-amino-1H-imidazol-4-yl)propyl]amino}-3-methyl-1-oxopentan-2-yl]carbamoyl}oxirane-2-carboxylic acid

(2S,3S)-3-{[(2R)-1-{[3-(2-amino-1H-imidazol-4-yl)propyl]amino}-3-methyl-1-oxopentan-2-yl]carbamoyl}oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

N-[4-[(3-phenylpropanoylamino)carbamoyl]phenyl]pentanamide

N-[4-[(3-phenylpropanoylamino)carbamoyl]phenyl]pentanamide

C21H25N3O3 (367.1896)


   

3-[(4-Ethoxycarbonyl-4-phenyl-1-piperidinyl)methyl]benzoic acid

3-[(4-Ethoxycarbonyl-4-phenyl-1-piperidinyl)methyl]benzoic acid

C22H25NO4 (367.1783)


   

3-ethoxy-N-[(4-methoxyphenyl)methyl]-2-propyl-6-indazolecarboxamide

3-ethoxy-N-[(4-methoxyphenyl)methyl]-2-propyl-6-indazolecarboxamide

C21H25N3O3 (367.1896)


   

WF14865B

WF14865B

C16H25N5O5 (367.1856)


A member of the class of guanidines isolated from the culture mycelium of the fungal strain Aphanoascus fulvescens and has been shown to exhibit inhibitory activity against cathepsin B and L.

   

WF14865A

WF14865A

C16H25N5O5 (367.1856)


A member of the class of guanidines isolated from the culture mycelium of the fungal strain Aphanoascus fulvescens and has been shown to exhibit inhibitory activity against cathepsin B and L.

   

3-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]oxirane-2-carboxylic acid

3-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl)-c-hydroxycarbonimidoyl]oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

(2e)-n-[(2r)-2-hydroxy-2-(4-{[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]oxy}phenyl)ethyl]-3-phenylprop-2-enimidic acid

(2e)-n-[(2r)-2-hydroxy-2-(4-{[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]oxy}phenyl)ethyl]-3-phenylprop-2-enimidic acid

C22H25NO4 (367.1783)


   

(2s,3s)-3-{[(1s,2s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s,2s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

n-[(2r)-2-hydroxy-2-(4-{[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]oxy}phenyl)ethyl]-3-phenylprop-2-enimidic acid

n-[(2r)-2-hydroxy-2-(4-{[(2s)-2-hydroxy-3-methylbut-3-en-1-yl]oxy}phenyl)ethyl]-3-phenylprop-2-enimidic acid

C22H25NO4 (367.1783)


   

(1s,4s,10s,12r)-12-hydroxy-1-(2-methylbut-3-en-2-yl)-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

(1s,4s,10s,12r)-12-hydroxy-1-(2-methylbut-3-en-2-yl)-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

C21H25N3O3 (367.1896)


   

alistonitrine A

NA

C21H25N3O3 (367.1896)


{"Ingredient_id": "HBIN015160","Ingredient_name": "alistonitrine A","Alias": "NA","Ingredient_formula": "C21H25N3O3","Ingredient_Smile": "CC1C2(O1)C3CC4C56C(C3C(=O)OC)(CCN5C2N4C)C7=CC=CC=C7N6","Ingredient_weight": "367.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35060","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102222299","DrugBank_id": "NA"}

   

(2s,3s)-3-{[(1s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

(2s,3s)-3-{[(1s)-1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-3-methylbutyl]-c-hydroxycarbonimidoyl}oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

7-hydroxy-2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

7-hydroxy-2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H25NO4 (367.1783)


   

5-({2-imino-5-[(4-methoxyphenyl)methyl]-1,3-dimethylimidazol-4-yl}methyl)-2-methoxyphenol

5-({2-imino-5-[(4-methoxyphenyl)methyl]-1,3-dimethylimidazol-4-yl}methyl)-2-methoxyphenol

C21H25N3O3 (367.1896)


   

(1s,2r,3s,5s,7r)-7-hydroxy-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1s,2r,3s,5s,7r)-7-hydroxy-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H25NO4 (367.1783)


   

(1r,2r,3r,5r,7s)-7-hydroxy-2-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

(1r,2r,3r,5r,7s)-7-hydroxy-2-[(r)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate

C22H25NO4 (367.1783)


   

(3s,8as)-1-hydroxy-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

(3s,8as)-1-hydroxy-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H25N3O3 (367.1896)


   

3-hydroxy-2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl benzoate

3-hydroxy-2-[hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl benzoate

C22H25NO4 (367.1783)


   

1-hydroxy-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

1-hydroxy-3-{[6-hydroxy-2-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]methyl}-3h,6h,7h,8h,8ah-pyrrolo[1,2-a]pyrazin-4-one

C21H25N3O3 (367.1896)


   

(12s,16s,17r,19r,20s)-22-hydroxy-16,20-dimethyl-4-oxa-14-azahexacyclo[15.4.1.0²,⁷.0⁸,²¹.0¹²,²⁰.0¹⁴,¹⁹]docosa-1(22),2(7),8(21)-triene-3,9-dione

(12s,16s,17r,19r,20s)-22-hydroxy-16,20-dimethyl-4-oxa-14-azahexacyclo[15.4.1.0²,⁷.0⁸,²¹.0¹²,²⁰.0¹⁴,¹⁹]docosa-1(22),2(7),8(21)-triene-3,9-dione

C22H25NO4 (367.1783)


   

3-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]oxirane-2-carboxylic acid

3-[(1-{[3-(2-imino-1,3-dihydroimidazol-4-yl)propyl]-c-hydroxycarbonimidoyl}-2-methylbutyl)-c-hydroxycarbonimidoyl]oxirane-2-carboxylic acid

C16H25N5O5 (367.1856)


   

(1s,2r,3r,5s,6s)-3-hydroxy-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl benzoate

(1s,2r,3r,5s,6s)-3-hydroxy-2-[(s)-hydroxy(phenyl)methyl]-8-methyl-8-azabicyclo[3.2.1]octan-6-yl benzoate

C22H25NO4 (367.1783)


   

22-hydroxy-16,20-dimethyl-4-oxa-14-azahexacyclo[15.4.1.0²,⁷.0⁸,²¹.0¹²,²⁰.0¹⁴,¹⁹]docosa-1(22),2(7),8(21)-triene-3,9-dione

22-hydroxy-16,20-dimethyl-4-oxa-14-azahexacyclo[15.4.1.0²,⁷.0⁸,²¹.0¹²,²⁰.0¹⁴,¹⁹]docosa-1(22),2(7),8(21)-triene-3,9-dione

C22H25NO4 (367.1783)


   

4,5,15,16-tetramethoxy-8,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

4,5,15,16-tetramethoxy-8,10-dimethyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

C22H25NO4 (367.1783)


   

12-hydroxy-1-(2-methylbut-3-en-2-yl)-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

12-hydroxy-1-(2-methylbut-3-en-2-yl)-2,8,19-triazapentacyclo[10.7.0.0²,¹⁰.0⁴,⁸.0¹³,¹⁸]nonadeca-13,15,17-triene-3,9-dione

C21H25N3O3 (367.1896)